This Article  • Full text PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

edited by Richard B. Patt, 650 pp, with illus, $72, Philadelphia, Pa, JB Lippincott, 1993.

Nathan I. Chemy, MBBS, FRACP, Reviewer
New York, NY

Arch Neurol. 1994;51(2):113.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Pain is experienced by 30% to 50% of ambulatory cancer patients and 75% to 90% of patients with advanced disease. The high prevalence of pain, neuro-oncologic complications of cancer, and neuropathic pain problems make the input of the neurologist an important part of the assessment and management of these patients. Unfortunately, the neurologist receives little specific training in cancer pain assessment or management, and the benefit that could potentially accrue from expert neurologic input often goes unrealized. Gonzales et al from the Memorial Sloan-Kettering Cancer Center (New York, NY) Neurology Pain Service have reported that evaluation resulted in the diagnosis of previously undetected lesions in 64% of consultations, many of which were amenable to primary therapies. There is need, therefore, for a clearly written comprehensive text on cancer pain that could provide the interested clinician with the information necessary to improve the management of these problems.

Cancer Pain, edited by . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?